[PDF][PDF] Old drug with new milestone: chloroquine and hydroxychloroquine in SARS-COV-2 (COVID-19) with multifaceted effects in other diseases

BA Yahya, BS Shabbir, BA Salam - Journal of Medical …, 2020 - researchgate.net
Hydroxychloroquine is one of the oldest and widely used anti-malarial drug which can be
beard easily with cost and well leeway, also these drugs have been greet to have efficacy in …

Combined therapy of ciclosporin plus favipiravir in the management of patients with severe COVID-19, not responding to dexamethasone: A non-controlled …

S Barati, SMR Hashemian, P Tabarsi, A Abedini… - International …, 2021 - Elsevier
Background Regarding the COVID-19 pandemic, potential therapeutic agents are being
evaluated almost every day. Ciclosporin, a calcineurin inhibitor, is characterized by …

Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection

A Klimke, G Hefner, B Will, U Voss - Medical hypotheses, 2020 - Elsevier
Covid-19 is a new coronavirus disease first described in December 2019. This respiratory
illness is severe and potentially fatal. Severe cases make up to 15%, lethality ranges …

Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses

J Ardanuy, R Johnson, C Dillen, L Taylor, H Hammond… - Mbio, 2023 - Am Soc Microbiol
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), continues to be one of the largest …

[HTML][HTML] Treatment options for COVID-19: The reality and challenges

SS Jean, PI Lee, PR Hsueh - Journal of microbiology, immunology and …, 2020 - Elsevier
An outbreak related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first reported in Wuhan, China in December 2019. An extremely high potential for …

Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19

N Shekhar, H Kaur, P Sarma, A Prakash… - Expert review of anti …, 2022 - Taylor & Francis
Introduction COVID-19, a dreadful pandemic that has impacted human life like no other
pathogenic invasion, has claimed the lives of over 100 million people. The need for effective …

Can sulfasalazine as an old drug with immunomodulatory and anti‐inflammatory effects be effective in COVID‐19?

M Ghasemnejad-Berenji - Journal of Basic and Clinical Physiology …, 2022 - degruyter.com
Coronavirus disease-2019 (COVID-19) is associated with different clinical manifestations;
among all, acute respiratory distress syndrome (ARDS) is the most dangerous [1]. It has …

[PDF][PDF] Diverse effects of clarithromycin and proposal of its clinical application for treating COVID-19 as a repurposing drug

N Takemori, HK Ooi, G Imai, M Saio - Tropical Biomedicine, 2021 - msptm.org
Outbreak of SARS-CoV-2 has been declared a pandemic, which is a serious threat to
human health. The disease was named coronavirus disease 2019 (COVID-19). Until now …

Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review

K Asadipooya, A Asadipooya, R Adatorwovor - Archives of Virology, 2024 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is still causing hospitalization and death,
and vaccination appears to become less effective with each emerging variant. Spike, non …

Fluoxetine can inhibit SARS-CoV-2 in vitro

A Dechaumes, MP Nekoua, S Belouzard, F Sane… - Microorganisms, 2021 - mdpi.com
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in
the coronavirus disease pandemic, drastically affecting global health and economy. Though …